- Al-Juburi, A.Z., & O'Donnell, P.D. (1990). Follow-up outcome of intracavernous papaverine. Journal of the Arkansas Medical Society, 86, 383–385.
- Buvat-Herbaut, M., & Buvat, J. (1987). Les r ésultats de la prise en charge d'inspiration sexologique dans les impuissances à participation organique. Psychogie Médicale, 19, 823–826.
- Dhabuwala, C.B. (1990). Intracavernous papaverine in the management of psychogenic impotence. Archives of Andrology, 24, 185–191.
- Gellman, R., & Gellman-Barroux, C. (1986). Réflexion critiques sur les impuissances d'origine vasculaire. Psychologie Médicale, 18, 399–401.
- Hatch, J.P. (1987). Psychometric differentiation of psychogenic and organic erectile disorders. Journal of Urology, 138, 781–783.
- Jantos, C. (1988). Langzeiterfahrungen mit der Autoinjektionstherapie von Papaverin bei erektiler Dysfunktion. Urologe [A], 2, 18–21.
- Kaplan, H.S. (1990). The combined use of sex therapy and intrapenile injections in the treatment of impotence. Journal of Sex & Marital Therapy, 16, 195–207.
- Larin, M.M. (1990). Intracavernous injection therapy: Analysis of results and complications. Journal of Urology, 143, 1138–1141.
- Melman, A., & Refield, J. (1981). Evaluation of the DSFI as a test of organic impotence. Sex and Disability, 4, 108–114.
- Nelson, R.P. (1989). Injection of papaverine and regitine into the corpora cavernosa for erectile dysfunction: Clinical results in 60 patients. Southern Medical Journal, 82, 26–28.
- Schramek, P. (1990). Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism. British Journal of Urology, 65, 68–71.
- Segraves, K.A., & Segraves, R.T. (1986). Differentiation of biogenic and psychogenic impotence with the Eysenck Personality Questionnaire and the Inventory of Sexual Attitudes. Personality and Individual Differences, 7, 423–425.
- Segraves, R.T. (1987). Discrimination between psychogenic and biogenic impotence utilizing psychometric instruments. Sexual Disability, 8, 138–142.
- Segraves, R.T. (1981a). Discrimination of organic versus psychological impotence with the DSFI: A failure to replicate. Journal of Sexual and Marital Therapy, 7, 230–238.
- Sidi, A.A. (1988). Patient acceptance of and satisfaction with vasoactive intracavernous pharmacotherapy for impotence. Journal of Urology, 140, 293–294.
- Stackl, W. (1988). Intracavernous injection of prostaglandin E1 in impotent men. Journal of Urology, 140, 66–68.
- Steffens, J. (1988). Ergebnisse und Akzeptanz der Schwellkörperautoinjektionstherapie (SKAT) bei organischer erektiler Dysfunktion. Urologe [A], 27, 14–16.
- Stief, C.G. (1987a). 2 Jahre Erfahrung mit der Schwellkörper-Autoinjektions-Therapie (SKAT). Urologe [A], 26, 294–296.
- Tiefer, L. (1986). In pursuit of the perfect penis: The medicalization of male sexuality. American Behavioral Scientist, 29, 579–599.
- Trapp, J.D. (1987). Pharmacologic erection program for the treatment of male impotence. Southern Medical Journal, 80, 426–427.
- Turner, L.A. (1989). Self-injection of papaverine and phentolamine in the treatment of psychogenic impotence. Journal of Sex and Marital Therapy, 15, 163–176.
- Virag, R. (1991). Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-years experience with 615 cases. Journal of Urology, 145, 287–293.
- Weiske, W.-H. (1989). Drei Jahre Erfahrungen mit der Schwellkörperautoinjektionstherapie. Urologe [A], 28, 253–257.
- Williams, G. (1987). Impotence: treatment by autoinjection of vasoactive drugs. British Medical Journal (Clinical Research), 295, 595–596.
- Zorgniotti, A.W., & LeFleur, R.S. (1985). Auto-injection of the corpus cavernosum with vasoactive drug combination for vasculogenic impotence. Journal of Urology, 133, 39–41.
Journal of Sex Education and Therapy
Volume 19, 1993 - Issue 1